Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KETAMINE vs KETOROLAC TROMETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

KETAMINE vs KETOROLAC TROMETHAMINE: Safety Overview

Metric KETAMINE KETOROLAC TROMETHAMINE
Total FAERS Reports 7,993 6,160
Deaths Reported 1,009 235
Death Rate 12.6% 3.8%
Hospitalizations 3,362 1,332
Average Patient Age 41.0 yrs 49.7 yrs
% Female Patients 46.7% 62.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 26, 1999
Manufacturer Eugia US LLC ASCLEMED USA INC.
Route INTRAMUSCULAR INTRAMUSCULAR
Marketing Status Prescription Discontinued